Parmax Pharma Limited

Transaction Details

Rupa Sunil Shah (identified as PAC 5 under the Open Offer) acquired 53,520 equity shares of face value ₹10.00 each of Parmax Pharma Limited ("Target Company") on June 16, 2026 through an off-market transaction.

Parties Involved

The acquirers are identified as:

  • Dhiren Chandulal Shah ("Acquirer 1")
  • Sunil Chinubhai Shah ("Acquirer 2")

Persons Acting in Concert (PACs) include:

  • Dhairya Dhiren Shah (PAC 1)
  • Hiren Pravin Doshi (PAC 2)
  • Sheetal Hiren Doshi (PAC 3)
  • Nirmal Sunilbhai Shah (PAC 4)
  • Rupa Sunil Shah (PAC 5)
  • Vijaykumar Natvarlal Shiyani (PAC 6)
  • Kamlesh Natvarlal Shiyani (PAC 7)
  • Abhay Chinubhai Shah (PAC 8)
  • Umang Alkesh Gosalia (PAC 9)
  • Meena Alkesh Gosalia (PAC 10)

Disclosure Status

Rupa Sunil Shah was previously disclosed as PAC 5 in the public announcement dated June 08, 2026 and the detailed public statement published on June 15, 2026.

Shareholding Impact

Total shareholding of acquirer and PACs after the acquisition:

  • Number of equity shares: 7,68,320
  • Percentage of total share capital: 20.54%